Review




Structured Review

Alpha Diagnostics mouse anti dsdna igg specific elisa kit
Mouse Anti Dsdna Igg Specific Elisa Kit, supplied by Alpha Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti+dsdna+igg+specific+elisa+kit/pmc13147688-251-0-8?v=Alpha+Diagnostics
Average 86 stars, based on 1 article reviews
mouse anti dsdna igg specific elisa kit - by Bioz Stars, 2026-07
86/100 stars

Images



Similar Products

86
Alpha Diagnostics mouse anti dsdna igg specific elisa kit
Mouse Anti Dsdna Igg Specific Elisa Kit, supplied by Alpha Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti+dsdna+igg+specific+elisa+kit/pmc13147688-251-0-8?v=Alpha+Diagnostics
Average 86 stars, based on 1 article reviews
mouse anti dsdna igg specific elisa kit - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

90
Alpha Diagnostics anti-mouse dsdna igg-specific elisa kit
Anti Mouse Dsdna Igg Specific Elisa Kit, supplied by Alpha Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti+dsdna+igg+specific+elisa+kit/pmc04334393__mmc1-102-20-25?v=Alpha+Diagnostics
Average 90 stars, based on 1 article reviews
anti-mouse dsdna igg-specific elisa kit - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

95
R&D Systems mouse anti dsdna igg specific elisa kit
Figure 2. Effects of in vivo rebamipide treatment on immune cell subsets and serologic phenotypes. (A,B) Immune cell subsets in splenocytes from 16-week-old mice treated with vehicle or rebamipide, analyzed by flow cytometry. (A) Percentages of double negative T (DNT, CD4−CD8−) cells, CD4+ T cells, T helper 1 (Th1, CD4+IFNg+) cells, regulatory T (Treg, CD4+CD25+Foxp3+) cells, CD8+ T cells, and T helper 2 (Th2, CD4+IL-4+) cells. (B) Percentages of plasma B cells (PC, CD19−CD138+) and IL- 10-producing B cells (B10, CD19+CD1d+CD5+IL-10+). (C) Serum levels of anti-dsDNA antibodies and immunoglobulin G2a (IgG2a) in the two groups of mice at 8, 12, and 16 weeks of age, determined by <t>ELISA.</t> Data are presented as medians with interquartile ranges. Statistical analyses were performed using the Mann–Whitney test (A,B) and two-way ANOVA (C). * p < 0.05.
Mouse Anti Dsdna Igg Specific Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti+dsdna+igg+specific+elisa+kit/10__3390_slash_ijms26125809-183-8-13?v=R%26D+Systems
Average 95 stars, based on 1 article reviews
mouse anti dsdna igg specific elisa kit - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier

90
MyBiosource Biotechnology mouse anti-dsdna igg-specific elisa kit
Figure 2. Effects of in vivo rebamipide treatment on immune cell subsets and serologic phenotypes. (A,B) Immune cell subsets in splenocytes from 16-week-old mice treated with vehicle or rebamipide, analyzed by flow cytometry. (A) Percentages of double negative T (DNT, CD4−CD8−) cells, CD4+ T cells, T helper 1 (Th1, CD4+IFNg+) cells, regulatory T (Treg, CD4+CD25+Foxp3+) cells, CD8+ T cells, and T helper 2 (Th2, CD4+IL-4+) cells. (B) Percentages of plasma B cells (PC, CD19−CD138+) and IL- 10-producing B cells (B10, CD19+CD1d+CD5+IL-10+). (C) Serum levels of anti-dsDNA antibodies and immunoglobulin G2a (IgG2a) in the two groups of mice at 8, 12, and 16 weeks of age, determined by <t>ELISA.</t> Data are presented as medians with interquartile ranges. Statistical analyses were performed using the Mann–Whitney test (A,B) and two-way ANOVA (C). * p < 0.05.
Mouse Anti Dsdna Igg Specific Elisa Kit, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti+dsdna+igg+specific+elisa+kit/pm40258389-69-15-20?v=MyBiosource+Biotechnology
Average 90 stars, based on 1 article reviews
mouse anti-dsdna igg-specific elisa kit - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Alpha Diagnostics mouse anti-dsdna igg-specific elisa kit
Figure 2. Effects of in vivo rebamipide treatment on immune cell subsets and serologic phenotypes. (A,B) Immune cell subsets in splenocytes from 16-week-old mice treated with vehicle or rebamipide, analyzed by flow cytometry. (A) Percentages of double negative T (DNT, CD4−CD8−) cells, CD4+ T cells, T helper 1 (Th1, CD4+IFNg+) cells, regulatory T (Treg, CD4+CD25+Foxp3+) cells, CD8+ T cells, and T helper 2 (Th2, CD4+IL-4+) cells. (B) Percentages of plasma B cells (PC, CD19−CD138+) and IL- 10-producing B cells (B10, CD19+CD1d+CD5+IL-10+). (C) Serum levels of anti-dsDNA antibodies and immunoglobulin G2a (IgG2a) in the two groups of mice at 8, 12, and 16 weeks of age, determined by <t>ELISA.</t> Data are presented as medians with interquartile ranges. Statistical analyses were performed using the Mann–Whitney test (A,B) and two-way ANOVA (C). * p < 0.05.
Mouse Anti Dsdna Igg Specific Elisa Kit, supplied by Alpha Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti+dsdna+igg+specific+elisa+kit/pm39664388-124-10-32?v=Alpha+Diagnostics
Average 90 stars, based on 1 article reviews
mouse anti-dsdna igg-specific elisa kit - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Alpha Diagnostics mouse anti-dsdna igg-specific elisa kit, cat. 5120
Figure 2. Effects of in vivo rebamipide treatment on immune cell subsets and serologic phenotypes. (A,B) Immune cell subsets in splenocytes from 16-week-old mice treated with vehicle or rebamipide, analyzed by flow cytometry. (A) Percentages of double negative T (DNT, CD4−CD8−) cells, CD4+ T cells, T helper 1 (Th1, CD4+IFNg+) cells, regulatory T (Treg, CD4+CD25+Foxp3+) cells, CD8+ T cells, and T helper 2 (Th2, CD4+IL-4+) cells. (B) Percentages of plasma B cells (PC, CD19−CD138+) and IL- 10-producing B cells (B10, CD19+CD1d+CD5+IL-10+). (C) Serum levels of anti-dsDNA antibodies and immunoglobulin G2a (IgG2a) in the two groups of mice at 8, 12, and 16 weeks of age, determined by <t>ELISA.</t> Data are presented as medians with interquartile ranges. Statistical analyses were performed using the Mann–Whitney test (A,B) and two-way ANOVA (C). * p < 0.05.
Mouse Anti Dsdna Igg Specific Elisa Kit, Cat. 5120, supplied by Alpha Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti+dsdna+igg+specific+elisa+kit/pm39242985-67-8-15?v=Alpha+Diagnostics
Average 90 stars, based on 1 article reviews
mouse anti-dsdna igg-specific elisa kit, cat. 5120 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Figure 2. Effects of in vivo rebamipide treatment on immune cell subsets and serologic phenotypes. (A,B) Immune cell subsets in splenocytes from 16-week-old mice treated with vehicle or rebamipide, analyzed by flow cytometry. (A) Percentages of double negative T (DNT, CD4−CD8−) cells, CD4+ T cells, T helper 1 (Th1, CD4+IFNg+) cells, regulatory T (Treg, CD4+CD25+Foxp3+) cells, CD8+ T cells, and T helper 2 (Th2, CD4+IL-4+) cells. (B) Percentages of plasma B cells (PC, CD19−CD138+) and IL- 10-producing B cells (B10, CD19+CD1d+CD5+IL-10+). (C) Serum levels of anti-dsDNA antibodies and immunoglobulin G2a (IgG2a) in the two groups of mice at 8, 12, and 16 weeks of age, determined by ELISA. Data are presented as medians with interquartile ranges. Statistical analyses were performed using the Mann–Whitney test (A,B) and two-way ANOVA (C). * p < 0.05.

Journal: International Journal of Molecular Sciences

Article Title: Rebamipide Attenuates Lupus Nephritis by Enhancing Antioxidative Defense in Podocytes: Evidence from a Lupus—Prone Mouse Model

doi: 10.3390/ijms26125809

Figure Lengend Snippet: Figure 2. Effects of in vivo rebamipide treatment on immune cell subsets and serologic phenotypes. (A,B) Immune cell subsets in splenocytes from 16-week-old mice treated with vehicle or rebamipide, analyzed by flow cytometry. (A) Percentages of double negative T (DNT, CD4−CD8−) cells, CD4+ T cells, T helper 1 (Th1, CD4+IFNg+) cells, regulatory T (Treg, CD4+CD25+Foxp3+) cells, CD8+ T cells, and T helper 2 (Th2, CD4+IL-4+) cells. (B) Percentages of plasma B cells (PC, CD19−CD138+) and IL- 10-producing B cells (B10, CD19+CD1d+CD5+IL-10+). (C) Serum levels of anti-dsDNA antibodies and immunoglobulin G2a (IgG2a) in the two groups of mice at 8, 12, and 16 weeks of age, determined by ELISA. Data are presented as medians with interquartile ranges. Statistical analyses were performed using the Mann–Whitney test (A,B) and two-way ANOVA (C). * p < 0.05.

Article Snippet: Collected sera from mice were assayed using the mouse anti-dsDNA IgG-specific ELISA kit (R&D systems) and anti-mouse immunoglobulin G2a (IgG2a) ELISA kit (Bethyl Laboratories, Montgomery, Tx, USA) according to the manufacturer’s instructions.

Techniques: In Vivo, Flow Cytometry, Clinical Proteomics, Enzyme-linked Immunosorbent Assay, MANN-WHITNEY

Figure 3. Effects of in vivo rebamipide treatment on renal manifestations. (A) Representative images of PAS-stained kidney tissues from mice treated with vehicle or rebamipide, showing glomerular (top) and perivascular (bottom) pathology. (B) Scores for glomerular pathology, tubular damage, and perivascular cell infiltration. (C) Urinary albumin/creatinine ratio (ACR) from each group of mice at 8, 12, and 16 weeks of age, measured by ELISA. Data are presented as medians with interquartile ranges. Statistical analyses were performed using the Mann–Whitney test (B) and two-way ANOVA (C). * p < 0.05, ** p < 0.01.

Journal: International Journal of Molecular Sciences

Article Title: Rebamipide Attenuates Lupus Nephritis by Enhancing Antioxidative Defense in Podocytes: Evidence from a Lupus—Prone Mouse Model

doi: 10.3390/ijms26125809

Figure Lengend Snippet: Figure 3. Effects of in vivo rebamipide treatment on renal manifestations. (A) Representative images of PAS-stained kidney tissues from mice treated with vehicle or rebamipide, showing glomerular (top) and perivascular (bottom) pathology. (B) Scores for glomerular pathology, tubular damage, and perivascular cell infiltration. (C) Urinary albumin/creatinine ratio (ACR) from each group of mice at 8, 12, and 16 weeks of age, measured by ELISA. Data are presented as medians with interquartile ranges. Statistical analyses were performed using the Mann–Whitney test (B) and two-way ANOVA (C). * p < 0.05, ** p < 0.01.

Article Snippet: Collected sera from mice were assayed using the mouse anti-dsDNA IgG-specific ELISA kit (R&D systems) and anti-mouse immunoglobulin G2a (IgG2a) ELISA kit (Bethyl Laboratories, Montgomery, Tx, USA) according to the manufacturer’s instructions.

Techniques: In Vivo, Staining, Enzyme-linked Immunosorbent Assay, MANN-WHITNEY